To clinic directors considering an M&A of their ophthalmology practice. When transferring your clinic, do you accurately understand the valuation and procedural points regarding high-value medical equipment such as cataract surgery devices and OCT, the valuation of LASIK and private-pay services, and most importantly, the transfer of your patients? Due to its high level of specialization, ophthalmology clinic M&A involves different valuation items compared to general clinic M&A. This article specifically explains the answers to questions that directors considering a transfer may have, in line with search intent. We encourage you to read it as the first step towards a successful M&A for your clinic.
The general guideline for the transfer price in ophthalmology clinic M&A tends to be around 0.5 to 1.5 times annual sales, or approximately 4 to 8 times EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization). However, this is merely a general guideline, and the profitability, location, obsolescence of medical equipment, patient numbers, electronic health record system, and future prospects of each individual clinic significantly influence the actual valuation. In particular, the valuation of high-value medical equipment like cataract surgery devices and OCT, the profitability of LASIK and private-pay services, and the establishment of a smooth patient transfer system are crucial factors that determine the final transfer price. Consulting with an M&A support organization is essential for professional valuation.
Valuation Standards and Key Points for Ophthalmology Clinic M&A
The transfer price in ophthalmology clinic M&A fluctuates based on various factors, but generally, the following elements are evaluated comprehensively. It is important for clinic directors considering a transfer to understand these valuation points to correctly grasp the value of their own clinic. The calculation of the transfer price primarily uses the following two approaches:
- Income Approach: This method focuses on the clinic’s future earning capacity and evaluates its present value. Future earnings are projected based on past financial data (sales, profits, EBITDA, etc.) and the present value is calculated using a discount rate. For ophthalmology clinics, the profitability of private-pay services such as LASIK, cataract surgery (private-pay), dry eye treatment, orthokeratology, and cosmetic procedures, in addition to insurance-based services, is emphasized.
- Cost Approach (Net Asset Method): This method evaluates the net asset value, which is the total assets minus total liabilities of the clinic. The fair market value of owned medical equipment (cataract surgery devices, OCT, laser equipment, etc.), electronic health record systems, and interior facilities is particularly important. Even for depreciated equipment, the valuation may vary depending on specific functions or the existence of maintenance contracts.
In addition to these approaches, location, patient numbers, patient demographics, the competitive landscape, and potential synergies for the acquirer (e.g., enhanced collaboration with surrounding medical institutions, expansion to existing customer bases) are also considered in determining the final transfer price.
| Evaluation Item | Impact on Transfer Price | Notes |
|---|---|---|
| Profitability (Insurance & Private Pay) | ◎ High | The revenue mix from LASIK, private-pay cataract surgery, and cosmetic procedures is important. Stable patient numbers and repeat visit rates are also evaluated. |
| High-Value Medical Equipment (Cataract Surgery Machines, OCT, etc.) | ○ Medium | The model, existence of maintenance contracts, and utilization rate affect the valuation. Whether the acquirer can utilize the equipment is key. |
| Electronic Health Record System | ○ Medium | Usability, functionality, ease of data migration, and maintenance support system. Potential for integration with other systems. |
| Patient Numbers & Demographics | ○ Medium | Stable patient numbers, repeat visit rates, age groups, and regional characteristics. |
| Location & Accessibility | ○ Medium | Distance from station, availability of parking, and surrounding competition. |
| Brand & Reputation | △ Low | Local recognition and word-of-mouth reviews. |
Ophthalmology Clinic Specific Valuation Items: High-Value Medical Equipment and Private-Pay Services
In ophthalmology clinic M&A, the high-value medical equipment owned and the profitability of private-pay services significantly influence the transfer price. How these are valued and reflected in the transfer price is key to a successful M&A.
1. Valuation of High-Value Medical Equipment
Cataract surgery devices, OCT (Optical Coherence Tomography), laser treatment devices, corneal topography, and fundus cameras are core medical equipment for ophthalmology clinics. The valuation of this equipment considers not only its simple used market price but also the following points:
- Model Obsolescence and Performance: The newer the model and the more advanced its diagnostic and treatment capabilities, the higher its valuation.
- Purchase Date and Remaining Useful Life: The extent of depreciation and how much longer it can be used are evaluation criteria.
- Maintenance Contracts: Whether regular maintenance contracts are in place and if the equipment is well-maintained.
- Acquirer’s Utilization Potential: Whether the acquirer can effectively utilize the equipment also affects its valuation. For example, if the acquirer already has the same model or plans to offer new services using this equipment.
2. Valuation of Private-Pay / Fee-for-Service Procedures
In ophthalmology clinics, in addition to insurance-based services, private-pay / fee-for-service procedures such as LASIK, ICL (Implantable Collamer Lens), advanced treatments and multifocal intraocular lenses for cataract surgery, orthokeratology, dry eye treatment, allergy treatment, and even cosmetic procedures (e.g., botulinum toxin therapy, hyaluronic acid injections) can be major sources of revenue. The valuation of these focuses on the following points:
- Profitability: Revenue and profit margins from private-pay / fee-for-service procedures, and their stability. Trends over the past few years are important.
- Patient Numbers and Repeat Visit Rates: Patient numbers for specific private-pay services, repeat visit rates, and referral rates.
- Marketing System: The effectiveness of marketing activities such as websites, social media, and advertisements aimed at acquiring patients for private-pay / fee-for-service procedures.
- Practitioner’s Expertise: The presence of physicians with expertise in specific procedures can also be a factor in valuation.
These valuation items are crucial for the acquirer to forecast their ability to maintain and expand revenue after taking over the clinic. Therefore, it is recommended that the seller prepare documentation that clearly demonstrates these strengths.
Patient Transfer: Considerations for a Smooth Transition
In the M&A of an ophthalmology clinic, the smooth transfer of existing patients is as important as, or even more important than, the transfer price. Establishing a system where patients can continue their treatment with peace of mind is essential for the acquirer to maintain and enhance the clinic’s value, and it is also extremely important for the seller to fulfill their responsibility to the patients they have cared for over many years.
To achieve a smooth patient transfer, the following points should be considered:
1. Information Linkage and Explanation
Establish methods for transferring patient medical records (medical history, test results, prescription history, etc.) to the new system, while ensuring patient privacy. If an electronic health record system is in place, the data migration plan is crucial. Furthermore, it is essential to develop a communication plan to carefully and clearly explain the M&A, the new physicians and staff, and any changes in the treatment system to the patients.
2. Continuity of Medical Services
It is important whether the acquirer can maintain the level of medical services and quality provided by the transferring clinic. Especially for highly specialized surgeries (e.g., cataract surgery) or specialized examinations and treatments, the skills of the acquiring physician and their ability to utilize the equipment will be tested. If necessary, a system where the transferring physician cooperates in technical guidance and handover for a certain period may be considered.
3. Staff Transfer
Transferring personnel such as nurses and receptionists, who are the face of the clinic, also contributes to patient peace of mind. Maintaining or improving staff employment conditions and benefits helps maintain motivation and promotes a smooth handover.
Based on these points, it is crucial for the seller and acquirer to cooperate in developing the best possible transfer plan for the patients, which will lead not only to a successful M&A but also to the future development of the clinic.
Transfer and Valuation of Electronic Health Records and Billing Systems in M&A
In the M&A of an ophthalmology clinic, the electronic health record (EHR) system and the medical billing system (reception computer) are crucial assets for operational efficiency, information management, and patient data. The transfer and valuation of these systems should be handled carefully during the M&A process.
1. System Evaluation Points
- Functionality: Does it cover necessary functions such as medical record keeping, test data management, prescription, billing, and appointment scheduling? Is integration with ophthalmology-specific examination equipment (OCT, fundus camera, etc.) smooth?
- Usability/UI: Can physicians and staff operate it intuitively? What is the learning curve?
- Maintenance & Support System: Is the support system provided by the vendor robust? Existence of maintenance contracts, costs, and contract duration.
- Ease of Data Migration: Is data migration to the acquirer’s existing system possible, or what are the associated costs and time?
- Security: Does it have robust security measures compliant with the Personal Information Protection Law?
- Customizability: Can it be customized to the clinic’s operational needs?
2. Transfer Schemes
There are primarily two methods for transferring EHR and billing systems:
- Transfer of the System Itself: The acquirer takes over the system used by the seller as is. This is effective if they are familiar with its operation or if it integrates easily with existing systems, but it may involve contract changes with the system vendor or compatibility issues with the acquirer’s current systems.
- Data Migration: Data is extracted from the seller’s system and migrated to the acquirer’s existing system. This often requires cooperation from the system vendor, and data format conversion and migration work can involve specialized knowledge, time, and costs.
Regarding reflection in the transfer price, in addition to the fair market value of the system, costs associated with data migration and the benefits for the acquirer of implementing or maintaining the system (e.g., improved operational efficiency, cost reduction) may be considered. M&A support organizations provide appropriate valuations and transfer scheme proposals, including these technical aspects.
How to Proceed with Ophthalmology Clinic M&A: Explained Step-by-Step
The M&A of an ophthalmology clinic proceeds through several stages, from planning to execution. Here, we explain the general M&A process from the seller’s perspective.
- Step 1: M&A Consideration & Preparation Clarify the purpose of considering M&A, set the desired transfer timeline, and organize the desired transfer conditions (price, transfer system, etc.). Identify your clinic’s strengths (medical equipment, private-pay services, patient base, etc.) and prepare for documentation.
- Step 2: Selection of M&A Support Organization Select an M&A brokerage or advisory firm specializing in medical M&A. Finding a reliable partner is key to a successful M&A.
- Step 3: Preliminary Assessment & Business Valuation The selected support organization will provide an estimated transfer price (preliminary assessment) based on your clinic’s financial status, profitability, assets (medical equipment, etc.), and patient numbers. A more detailed business valuation will also be conducted.
- Step 4: Search & Selection of Potential Buyers The support organization will search for potential buyers (other ophthalmology clinics, medical corporations, business companies, etc.) that meet your desired conditions and arrange meetings with them. After signing a Non-Disclosure Agreement (NDA), an overview of your clinic (Non-Name Sheet) will be disclosed.
- Step 5: Signing of Memorandum of Understanding (MOU) If an agreement is reached with a potential buyer regarding the transfer price, basic M&A conditions, and exclusivity, a Memorandum of Understanding (MOU) will be signed.
- Step 6: Due Diligence (DD) The buyer will conduct a detailed investigation (due diligence) of your clinic’s finances, legal aspects, and business operations. The seller will provide requested documents and respond to inquiries.
- Step 7: Signing of Final Agreement (Share Transfer Agreement, etc.) Based on the results of the DD, the final transfer price and contract terms will be negotiated, and the final agreement (e.g., Share Transfer Agreement, Business Transfer Agreement) will be signed.
- Step 8: M&A Closing & PMI Based on the agreement, the transfer price will be paid, and the rights and obligations of the clinic will be transferred (closing). Subsequently, the post-merger integration (PMI) process will be led by the buyer.
Key Points for a Successful Transfer and FAQ
Professional knowledge and experience are essential for a successful M&A of an ophthalmology clinic. Here, we answer common questions from clinic directors considering a transfer.
Q1: How are “patient numbers,” which are most emphasized in M&A, specifically counted?
A1: Generally, it is counted by the number of unique patients (IDs) who have received treatment within a certain period (e.g., the last year). However, it is not just about the quantity; there is a tendency to evaluate comprehensively, including the proportion of patients receiving regular maintenance or ongoing treatment, their age groups, and the potential for transitioning to private-pay services.
Q2: Will high-value medical equipment like cataract surgery devices be valued lower than their purchase price?
A2: It depends on the degree of obsolescence, the status of maintenance contracts, and how much the acquirer can utilize the equipment. If it’s a new model with a solid maintenance contract, it might be valued close to the purchase price, but generally, the valuation is based on the used market price and remaining useful life. The benefits for the acquirer of acquiring the equipment (e.g., offering new surgical procedures, replacing existing equipment) may also be reflected in the valuation.
Q3: How is the profitability of private-pay services such as LASIK and cosmetic procedures evaluated?
A3: The profitability of private-pay / fee-for-service procedures is a crucial evaluation item in M&A. Sales revenue and profit margins over the past few years, as well as their stability, are closely examined. In particular, if high profitability is maintained through effective marketing strategies and practitioner expertise, it becomes a factor that enhances the clinic’s value. The acquirer assesses whether they can inherit and maintain/expand that profitability.
Q4: How much information about the clinic needs to be disclosed to potential buyers during M&A negotiations?
A4: In the initial stages, confidential information such as detailed financial data and customer lists will not be disclosed. After signing a Non-Disclosure Agreement (NDA), an overview of the clinic (Non-Name Sheet) will be provided. Detailed information will be disclosed during the due diligence (DD) phase after the potential buyer expresses interest and a basic agreement is reached. M&A support organizations provide appropriate advice on the scope and timing of disclosure.
Q5: How long does the M&A process typically take?
A5: While it depends on the clinic’s size and conditions, as well as negotiations with potential buyers, the process from consulting with an M&A support organization to signing the final agreement generally takes about six months to a year. Due diligence and various procedures may require time.